Preprocedural mouth rinses for preventing transmission of infectious diseases through aerosols in dental healthcare providers.
Journal
The Cochrane database of systematic reviews
ISSN: 1469-493X
Titre abrégé: Cochrane Database Syst Rev
Pays: England
ID NLM: 100909747
Informations de publication
Date de publication:
22 08 2022
22 08 2022
Historique:
entrez:
22
8
2022
pubmed:
23
8
2022
medline:
25
8
2022
Statut:
epublish
Résumé
Aerosols and spatter are generated in a dental clinic during aerosol-generating procedures (AGPs) that use high-speed hand pieces. Dental healthcare providers can be at increased risk of transmission of diseases such as tuberculosis, measles and severe acute respiratory syndrome (SARS) through droplets on mucosae, inhalation of aerosols or through fomites on mucosae, which harbour micro-organisms. There are ways to mitigate and contain spatter and aerosols that may, in turn, reduce any risk of disease transmission. In addition to personal protective equipment (PPE) and aerosol-reducing devices such as high-volume suction, it has been hypothesised that the use of mouth rinse by patients before dental procedures could reduce the microbial load of aerosols that are generated during dental AGPs. To assess the effects of preprocedural mouth rinses used in dental clinics to minimise incidence of infection in dental healthcare providers and reduce or neutralise contamination in aerosols. We used standard, extensive Cochrane search methods. The latest search date was 4 February 2022. We included randomised controlled trials and excluded laboratory-based studies. Study participants were dental patients undergoing AGPs. Studies compared any preprocedural mouth rinse used to reduce contaminated aerosols versus placebo, no mouth rinse or another mouth rinse. Our primary outcome was incidence of infection of dental healthcare providers and secondary outcomes were reduction in the level of contamination of the dental operatory environment, cost, change in mouth microbiota, adverse events, and acceptability and feasibility of the intervention. Two review authors screened search results, extracted data from included studies, assessed the risk of bias in the studies and judged the certainty of the available evidence. We used mean differences (MDs) and 95% confidence intervals (CIs) as the effect estimate for continuous outcomes, and random-effects meta-analysis to combine data MAIN RESULTS: We included 17 studies with 830 participants aged 18 to 70 years. We judged three trials at high risk of bias, two at low risk and 12 at unclear risk of bias. None of the studies measured our primary outcome of the incidence of infection in dental healthcare providers. The primary outcome in the studies was reduction in the level of bacterial contamination measured in colony-forming units (CFUs) at distances of less than 2 m (intended to capture larger droplets) and 2 m or more (to capture droplet nuclei from aerosols arising from the participant's oral cavity). It is unclear what size of CFU reduction represents a clinically significant amount. There is low- to very low-certainty evidence that chlorhexidine (CHX) may reduce bacterial contamination, as measured by CFUs, compared with no rinsing or rinsing with water. There were similar results when comparing cetylpyridinium chloride (CPC) with no rinsing and when comparing CPC, essential oils/herbal mouthwashes or boric acid with water. There is very low-certainty evidence that tempered mouth rinses may provide a greater reduction in CFUs than cold mouth rinses. There is low-certainty evidence that CHX may reduce CFUs more than essential oils/herbal mouthwashes. The evidence for other head-to-head comparisons was limited and inconsistent. The studies did not provide any information on costs, change in micro-organisms in the patient's mouth or adverse events such as temporary discolouration, altered taste, allergic reaction or hypersensitivity. The studies did not assess acceptability of the intervention to patients or feasibility of implementation for dentists. AUTHORS' CONCLUSIONS: None of the included studies measured the incidence of infection among dental healthcare providers. The studies measured only reduction in level of bacterial contamination in aerosols. None of the studies evaluated viral or fungal contamination. We have only low to very low certainty for all findings. We are unable to draw conclusions regarding whether there is a role for preprocedural mouth rinses in reducing infection risk or the possible superiority of one preprocedural rinse over another. Studies are needed that measure the effect of rinses on infectious disease risk among dental healthcare providers and on contaminated aerosols at larger distances with standardised outcome measurement.
Sections du résumé
BACKGROUND
Aerosols and spatter are generated in a dental clinic during aerosol-generating procedures (AGPs) that use high-speed hand pieces. Dental healthcare providers can be at increased risk of transmission of diseases such as tuberculosis, measles and severe acute respiratory syndrome (SARS) through droplets on mucosae, inhalation of aerosols or through fomites on mucosae, which harbour micro-organisms. There are ways to mitigate and contain spatter and aerosols that may, in turn, reduce any risk of disease transmission. In addition to personal protective equipment (PPE) and aerosol-reducing devices such as high-volume suction, it has been hypothesised that the use of mouth rinse by patients before dental procedures could reduce the microbial load of aerosols that are generated during dental AGPs.
OBJECTIVES
To assess the effects of preprocedural mouth rinses used in dental clinics to minimise incidence of infection in dental healthcare providers and reduce or neutralise contamination in aerosols.
SEARCH METHODS
We used standard, extensive Cochrane search methods. The latest search date was 4 February 2022.
SELECTION CRITERIA
We included randomised controlled trials and excluded laboratory-based studies. Study participants were dental patients undergoing AGPs. Studies compared any preprocedural mouth rinse used to reduce contaminated aerosols versus placebo, no mouth rinse or another mouth rinse. Our primary outcome was incidence of infection of dental healthcare providers and secondary outcomes were reduction in the level of contamination of the dental operatory environment, cost, change in mouth microbiota, adverse events, and acceptability and feasibility of the intervention.
DATA COLLECTION AND ANALYSIS
Two review authors screened search results, extracted data from included studies, assessed the risk of bias in the studies and judged the certainty of the available evidence. We used mean differences (MDs) and 95% confidence intervals (CIs) as the effect estimate for continuous outcomes, and random-effects meta-analysis to combine data MAIN RESULTS: We included 17 studies with 830 participants aged 18 to 70 years. We judged three trials at high risk of bias, two at low risk and 12 at unclear risk of bias. None of the studies measured our primary outcome of the incidence of infection in dental healthcare providers. The primary outcome in the studies was reduction in the level of bacterial contamination measured in colony-forming units (CFUs) at distances of less than 2 m (intended to capture larger droplets) and 2 m or more (to capture droplet nuclei from aerosols arising from the participant's oral cavity). It is unclear what size of CFU reduction represents a clinically significant amount. There is low- to very low-certainty evidence that chlorhexidine (CHX) may reduce bacterial contamination, as measured by CFUs, compared with no rinsing or rinsing with water. There were similar results when comparing cetylpyridinium chloride (CPC) with no rinsing and when comparing CPC, essential oils/herbal mouthwashes or boric acid with water. There is very low-certainty evidence that tempered mouth rinses may provide a greater reduction in CFUs than cold mouth rinses. There is low-certainty evidence that CHX may reduce CFUs more than essential oils/herbal mouthwashes. The evidence for other head-to-head comparisons was limited and inconsistent. The studies did not provide any information on costs, change in micro-organisms in the patient's mouth or adverse events such as temporary discolouration, altered taste, allergic reaction or hypersensitivity. The studies did not assess acceptability of the intervention to patients or feasibility of implementation for dentists. AUTHORS' CONCLUSIONS: None of the included studies measured the incidence of infection among dental healthcare providers. The studies measured only reduction in level of bacterial contamination in aerosols. None of the studies evaluated viral or fungal contamination. We have only low to very low certainty for all findings. We are unable to draw conclusions regarding whether there is a role for preprocedural mouth rinses in reducing infection risk or the possible superiority of one preprocedural rinse over another. Studies are needed that measure the effect of rinses on infectious disease risk among dental healthcare providers and on contaminated aerosols at larger distances with standardised outcome measurement.
Identifiants
pubmed: 35994295
doi: 10.1002/14651858.CD013826.pub2
pmc: PMC9394685
doi:
Substances chimiques
Mouthwashes
0
Oils, Volatile
0
Water
059QF0KO0R
Chlorhexidine
R4KO0DY52L
Types de publication
Journal Article
Meta-Analysis
Review
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
CD013826Informations de copyright
Copyright © 2022 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Références
J Periodontol. 2013 Sep;84(9):1297-308
pubmed: 23121460
Recent Pat Drug Deliv Formul. 2015;9(3):257-61
pubmed: 26051152
Br Dent J. 2004 Aug 14;197(3):130-4
pubmed: 15311240
J Periodontol. 2014 Apr;85(4):562-8
pubmed: 23855840
J Am Dent Assoc. 1993 May;124(5):56-8
pubmed: 8292118
J Am Dent Assoc. 2010 Apr;141(4):415-22
pubmed: 20354090
Int J Oral Surg. 1976 Dec;5(6):276-84
pubmed: 826491
Periodontol 2000. 1997 Oct;15:55-62
pubmed: 9643233
J Hosp Infect. 2020 Dec;106(4):657-662
pubmed: 33058941
J Ayurveda Integr Med. 2016 Jul - Sep;7(3):141-143
pubmed: 27658912
J Am Dent Assoc. 1994 Aug;125 Suppl 2:2S-10S
pubmed: 8064061
Br Dent J. 1987 Aug 22;163(4):118-9
pubmed: 3307852
Cochrane Database Syst Rev. 2022 Aug 22;8:CD013826
pubmed: 35994295
Clin Oral Investig. 2020 Oct;24(10):3707-3713
pubmed: 32876748
J Dent Res. 2020 May;99(5):481-487
pubmed: 32162995
J Clin Periodontol. 2003;30 Suppl 5:22-4
pubmed: 12787200
Saudi Dent J. 2018 Jan;30(1):2-6
pubmed: 30166864
J Contemp Dent Pract. 2013 Sep 01;14(5):848-51
pubmed: 24685786
J Hosp Infect. 2000 Dec;46(4):241-56
pubmed: 11170755
Int J Clin Pract. 2015 Nov;69(11):1247-56
pubmed: 26249761
J Periodontol. 1998 Apr;69(4):434-8
pubmed: 9609373
Mol Oral Microbiol. 2020 Aug;35(4):141-145
pubmed: 32367576
J Oral Microbiol. 2012;4:
pubmed: 22701774
Med Hypotheses. 2021 Jan;146:110436
pubmed: 33288313
Compend Contin Educ Dent. 2000 Jan;21(1):59-62, 64, 66 passim; quiz 78
pubmed: 11199690
J Prosthodont. 2020 Jul;29(6):529-533
pubmed: 32511851
J Am Dent Assoc. 2004 Apr;135(4):429-37
pubmed: 15127864
Am J Dent. 1993 Oct;6(5):219-21
pubmed: 7880461
Oral Microbiol Immunol. 2004 Aug;19(4):240-6
pubmed: 15209994
J Am Dent Assoc. 1964 Dec;69:715-8
pubmed: 14212043
J Korean Med Sci. 2020 May 25;35(20):e195
pubmed: 32449329
Indian J Dent Res. 2014 Mar-Apr;25(2):160-5
pubmed: 24992844
J Contemp Dent Pract. 2012 Sep 01;13(5):681-9
pubmed: 23250175
Maxillofac Plast Reconstr Surg. 2020 Apr 24;42(1):12
pubmed: 32341913
J Infect Dis. 2020 Sep 14;222(8):1289-1292
pubmed: 32726430
J Occup Environ Med. 2015 May;57(5):501-8
pubmed: 25816216
Evid Based Complement Alternat Med. 2020 Jan 20;2020:2829854
pubmed: 32419797
Cochrane Database Syst Rev. 2020 Oct 12;10:CD013686
pubmed: 33047816
Int J Dent Hyg. 2011 Aug;9(3):171-81
pubmed: 21356027
Oral Surg Oral Med Oral Pathol. 1970 Feb;29(2):291-4
pubmed: 4904188
Acta Odontol Scand. 2021 Jan;79(1):69-80
pubmed: 33307917
J Dent Hyg. 1993 Sep-Oct;67(6):312-7
pubmed: 17233164
J Infect Public Health. 2015 May-Jun;8(3):260-5
pubmed: 25564419
J Am Dent Assoc. 2020 Nov;151(11):815-824
pubmed: 33071007
J Am Dent Assoc. 2019 Dec;150(12):1015-1026.e1
pubmed: 31761015
J Oral Microbiol. 2020 Jul 17;12(1):1794363
pubmed: 32944152
J Dent Res. 2008 Feb;87(2):148-52
pubmed: 18218841
Anesth Prog. 2020 Sep 1;67(3):127-134
pubmed: 32556161
Braz Oral Res. 2017 Mar 30;31:e21
pubmed: 28380086
Res Synth Methods. 2020 Sep;11(5):617-626
pubmed: 32472632
Microb Pathog. 2021 Mar;152:104620
pubmed: 33212200
Contemp Clin Dent. 2021 Jul-Sep;12(3):282-288
pubmed: 34759686
Angle Orthod. 2001 Aug;71(4):299-306
pubmed: 11510639
MMWR Recomm Rep. 2003 Dec 19;52(RR-17):1-61
pubmed: 14685139
Aust Dent J. 2000 Dec;45(4):257-69; quiz 289
pubmed: 11225528
J Dent Res. 2020 Oct;99(11):1228-1238
pubmed: 32660314
Indian J Dent Res. 2018 Mar-Apr;29(2):225-232
pubmed: 29652019
Oral Surg Oral Med Oral Pathol. 1970 Jan;29(1):25-30
pubmed: 4902663
Ther Adv Drug Saf. 2019 Sep 23;10:2042098619854881
pubmed: 31579502
Pathog Immun. 2017;2(2):252-269
pubmed: 28936484
Cochrane Database Syst Rev. 2020 Sep 16;9:CD013627
pubmed: 32936948
Clin Microbiol Infect. 2020 Nov;26(11):1520-1524
pubmed: 32711057
Microbiol Spectr. 2016 Apr;4(2):
pubmed: 27227291
PLoS One. 2017 May 22;12(5):e0178007
pubmed: 28531183
BMJ Open Respir Res. 2020 Oct;7(1):
pubmed: 33040021
J Indian Soc Periodontol. 2012 Apr;16(2):213-7
pubmed: 23055587
J Am Dent Assoc. 2015 Aug;146(8):610-622
pubmed: 26227646
Infect Dis Ther. 2018 Jun;7(2):249-259
pubmed: 29633177
ScientificWorldJournal. 2015;2015:712683
pubmed: 25874255
Clin Microbiol Infect. 2020 Oct;26(10):1395-1399
pubmed: 32603803
Quintessence Int. 2019;50(1):58-65
pubmed: 30600327
Gen Dent. 2001 Nov-Dec;49(6):648-52
pubmed: 12024755
Jpn J Vet Res. 2004 Nov;52(3):105-12
pubmed: 15631008
Dental Press J Orthod. 2014 May-Jun;19(3):95-101
pubmed: 25162572
Clin Oral Implants Res. 2002 Feb;13(1):20-9
pubmed: 12005141
Front Med (Lausanne). 2021 Jun 10;8:600769
pubmed: 34179030
Clin Infect Dis. 2020 Jul 28;71(15):841-843
pubmed: 32047895
J Am Dent Assoc. 1996 May;127(5):641-2, 645-6
pubmed: 8642144
Infection. 2021 Apr;49(2):305-311
pubmed: 33315181
Am J Orthod Dentofacial Orthop. 2016 Nov;150(5):831-838
pubmed: 27871710
Antimicrob Agents Chemother. 1988 Mar;32(3):350-3
pubmed: 3364952
J Oral Maxillofac Pathol. 2016 Jan-Apr;20(1):59-65
pubmed: 27194863
J Am Dent Assoc. 1994 Aug;125 Suppl 2:29S-32S
pubmed: 8064064
J Int Acad Periodontol. 2017 Oct 1;19(4):138-144
pubmed: 31473729
Cochrane Database Syst Rev. 2020 Apr 15;4:CD011621
pubmed: 32293717
Imaging Sci Dent. 2014 Jun;44(2):149-54
pubmed: 24944965
Dent Mater. 2010 Aug;26(8):779-85
pubmed: 20472282
J Indian Soc Periodontol. 2020 Jan-Feb;24(1):37-41
pubmed: 31983843
J Clin Diagn Res. 2016 May;10(5):ZC81-3
pubmed: 27437366
Eur J Clin Microbiol Infect Dis. 2019 Nov;38(11):2005-2019
pubmed: 31372904
Am J Orthod Dentofacial Orthop. 2020 Sep;158(3):330-342
pubmed: 32682661
J Periodontol. 1992 Oct;63(10):821-4
pubmed: 1403589
J Dent Hyg. 1992 Sep;66(7):314-8
pubmed: 1291635
J Am Dent Assoc. 1995 Dec;126(12):1634-9
pubmed: 7499664
J Clin Diagn Res. 2015 Apr;9(4):ZC52-7
pubmed: 26023644